Ethyl 5-bromo-4-(3-chlorophenyl)-1,3-thiazole-2-carboxylate → 4-(3-Chlorophenyl)-5-(3-cyanophenyl)-1,3-thiazole-2-carboxylic acid

HRID 2038370Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 2038370
[Cl:1][C:2]1[CH:3]=[C:4]([C:9]2[N:10]=[C:11]([C:22]([OH:24])=[O:23])[S:12][C:13]=2[C:14]2[CH:19]=[C:18](F)[CH:17]=[C:16](Cl)[CH:15]=2)[CH:5]=[CH:6][C:7]=1F.BrC1SC(C(OCC)=O)=[N:28][C:27]=1C1C=CC=C(Cl)C=1>>[Cl:1][C:2]1[CH:3]=[C:4]([C:9]2[N:10]=[C:11]([C:22]([OH:24])=[O:23])[S:12][C:13]=2[C:14]2[CH:19]=[CH:18][CH:17]=[C:16]([C:27]#[N:28])[CH:15]=2)[CH:5]=[CH:6][CH:7]=1

Komponenten

3

Versuchsvorschrift

The preparation of the title compound takes place in analogy to the synthesis of the compound from Example 8A starting with the compound from Example 5A. 556 mg of the title compound having a purity of 41% (46% of theory) are obtained.

Quellen und Nachweise

ORD-Eintrag
ord-c9b54eaf49634cc1835f3ad8ab805fdd
Quelldatensatz
uspto-grants-2013_11
Patentnummer
US08575357B2

Notizen zur Reaktion

Wird geladen…